Contineum Therapeutics, Inc. (CTNM)
Nasdaq: CTNM · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2023
Who runs Contineum Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Stengone Carmine N.
CEO and President. First filing Apr 2024, latest Sep 8, 2026, 6 filings in all.
Officers reporting now
5
of 12 people with a filing in the last fifteen months
Directors reporting now
7
13 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Stengone Carmine N. | CEO and President | Apr 2024 | Sep 8, 2026 | 7 · $400,000 |
| Lorrain Daniel S. | Chief Scientific Officer | Apr 2024 | Jul 10, 2026 | 19 · $1.1M |
| Watkins Tim | CMO & Head of Development | Apr 2025 | Jul 1, 2026 | 5 · $300,000 |
| Slover Peter T | Chief Financial Officer | Apr 2024 | Jan 30, 2026 | none |
| Healy John Stephen | General Counsel and Corp Sec | Jun 2024 | Jan 30, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Boyce Sarah | director | Jun 2024 | Jun 26, 2026 | none |
| Brady Todd R. | director | Apr 2024 | Jun 26, 2026 | none |
| Ignelzi Troy A. | director | May 2024 | Jun 26, 2026 | none |
| Lyons-Williams Lori | director | Apr 2024 | Jun 26, 2026 | none |
| Miralles Gines Diego | director | Mar 2025 | Jun 26, 2026 | none |
| Schimmelpennink Evert B. | director | Apr 2024 | Jun 26, 2026 | none |
| Ware Olivia C | director | Apr 2024 | Jun 26, 2026 | none |
Earlier names on the record12, newest filing first
Huhn Stephen L. · officer · last filing Jan 2025Versant Side Fund IV, L.P. · 10% owner · last filing Apr 2024Versant Vantage I Gp-Gp, LLC · 10% owner · last filing Apr 2024Versant Vantage I Gp, L.P. · 10% owner · last filing Apr 2024Versant Vantage I, L.P. · 10% owner · last filing Apr 2024Versant Venture Capital IV, L.P. · 10% owner · last filing Apr 2024Versant Venture Capital Vi, L.P. · 10% owner · last filing Apr 2024Versant Ventures IV, LLC · 10% owner · last filing Apr 2024Versant Ventures Vi Gp-Gp, LLC · 10% owner · last filing Apr 2024Versant Ventures Vi Gp, L.P. · 10% owner · last filing Apr 2024Johnson & Johnson · 10% owner · last filing Apr 2024Johnson & Johnson Innovation - Jjdc, Inc. · 10% owner · last filing Apr 2024
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.